Skip to main content
. 2017 Aug 11;152(4):562–573. doi: 10.1111/imm.12792

Figure 2.

Figure 2

Latent membrane protein 1 (LMP1) expression in Epstein–Barr virus (EBV) ‐positive diffuse large B‐cell lymphoma (DLBCL) cell lines after 3 days of interleukin‐4 (IL‐4) or IL‐21 treatment. (a,b) Immunoblot analysis of total cell extracts of Farage, Val, DOHH2 and OPL2 lines treated with 50 ng/ml IL‐4 or 100 ng/ml IL‐21 for 3 days with β‐actin and LMP1 (S12) antibodies.